Chimeric Therapeutics

Chimeric Therapeutics

Biotechnology-Research

Carlton, Victoria
Australia
Company Tagline

Pioneers in Cell Therapy ASX:CHM

Industry Category
Biotechnology-Research
Company Description

Chimeric Therapeutics is a leading biotechnology research company focused on discovering, developing, and commercializing innovative cell therapies with significant potential for patients. As a pioneer in the field, Chimeric Therapeutics is dedicated to advancing the next generation of cell-based treatments. Located at 62 Lygon St, LEVEL 3, Carlton, Victoria 3053, AU, Chimeric Therapeutics is committed to making a difference in the lives of individuals through cutting-edge research and development.

With a strong focus on biotechnology, cancer research, and drug development, Chimeric Therapeutics leverages its expertise in life sciences, biotech, cell therapy, immuno-oncology, and immunotherapy to create impactful therapies. Chimeric Therapeutics strives to improve patient outcomes and transform the future of medicine. The company’s dedication to innovation drives its mission to deliver novel solutions that address unmet medical needs.

Chimeric Therapeutics is poised for continued growth and success in the dynamic biotechnology landscape. We invite the manager of Chimeric Therapeutics to create a customized and exclusive company showcase and product listing on our platform, enhancing visibility and engagement within the industry.

Chimeric Therapeutics est une société leader de recherche biotechnologique axée sur la découverte, le développement et la commercialisation de thérapies cellulaires innovantes avec un potentiel significatif pour les patients. En tant que pionnier dans le domaine, Chimeric Therapeutics se consacre à faire progresser la prochaine génération de traitements à base de cellules. Située au 62 Lygon St, LEVEL 3, Carlton, Victoria 3053, AU, Chimeric Therapeutics s'engage à faire une différence dans la vie des individus grâce à la recherche et au développement de pointe.

Avec un fort accent sur la biotechnologie, la recherche sur le cancer et le développement de médicaments, Chimeric Therapeutics exploite son expertise dans les sciences de la vie, la biotechnologie, la thérapie cellulaire, l'immuno-oncologie et l'immunothérapie pour créer des thérapies percutantes. Chimeric Therapeutics s'efforce d'améliorer les résultats pour les patients et de transformer l'avenir de la médecine. Le dévouement de l'entreprise à l'innovation anime sa mission de fournir des solutions novatrices qui répondent aux besoins médicaux non satisfaits.

Chimeric Therapeutics est prête à poursuivre sa croissance et son succès dans le paysage biotechnologique dynamique. Nous invitons le responsable de Chimeric Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, améliorant ainsi la visibilité et l'engagement au sein de l'industrie.

Key Personnel / Employees
Jason Litten Eugene Helsel Paul Hopper Agathe Bourgogne

Compare Companies Side by Side

Compare Chimeric Therapeutics with 3 companies in Biotechnology-Research

4 Companies
Comparison Field
Chimeric Therapeutics
Chimeric Therapeutics
Main Company
MaxCyte, Inc.
MaxCyte, Inc.
View Profile
Morgan Prestwich - Life Science & Healthcare Executive Search
Morgan Prestwich - L...
View Profile
Founded Year
1971 1999 2010
Company Size
201-500 51-200 11-50
City
Carlton, Victoria Lincoln, NE Rockville, Maryland Reigate, Surrey
Country
Australia United States United States United Kingdom
Skills & Keywords Comparing with main company
9 Total Skills
Biotechnology Cell Therapy Immunooncology Cancer Research Drug Development Biotech Immunotherapy drug development Life Sciences
10 Total 10 Unique
Unique Skills:
Biologics Biology Drug Discovery Microbiology Molecular Biology Protein Research +4
16 Total 16 Unique
Unique Skills:
Bispecifics Cancer CARMA Cell Engineering Electroporation Gene Editing +10
53 Total 53 Unique
Unique Skills:
Biotech Recruitment Biotechnology Recruitment Boards Business Development C-Level Commercialisation +47
4
Total Companies
1971
Oldest Founded
3
Countries
86
Unique Skills

Similar Companies

Other organizations in the same industry

Sigma-Aldrich
Biotechnology-Research
St. Louis, MO
United States
pardisgene
Biotechnology-Research
Apobiologix
Biotechnology-Research
Toronto, Ontario
Canada
Singlera Genomics Incorporated
Biotechnology-Research

Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).

La Jolla, California
United States

Alternative Company Names

This company is also known as

Chimeric Therapeutics 嵌合疗法 काइमेरिक थेरेप्यूटिक्स الخلايا العلاجية الوهمية Химерная терапия